This seminar will present an overview of the use of GLP-1 receptor agonists (GLP1RAs) around pregnancy, addressing current evidence and clinical considerations for preconception, pregnancy, and lactation. We will discuss the emerging data regarding GLP1RA exposure and its implications for pregnancy outcomes. The seminar will also evaluate the risk-benefit profile of using GLP1RAs around the time of conception, highlighting recent research findings that inform clinical decision-making. Additionally, lactation considerations will be reviewed. By the conclusion of the presentation, attendees will have a clearer understanding of the current evidence regarding GLP1RA use before, during, and after pregnancy.

About the Speaker

Camille E. Powe M.D.
Co-Director, Diabetes in Pregnancy Program
Massachusetts General Hospital | Mass General Brigham
Associate Professor of Medicine, Associate Professor of Obstetrics, Gynecology, and Reproductive Biology
Harvard Medical School

Dr. Camille Powe is a physician-investigator in the Diabetes Unit at Massachusetts General Hospital and an Associate Professor of both Medicine and Obstetrics, Gynecology, and Reproductive Biology at Harvard Medical School. Her clinical and scientific focus is metabolic disease in pregnancy. Clinically, she is an adult endocrinologist and a Founder and Co-Director of the Massachusetts General Hospital Diabetes in Pregnancy Program. Her interdisciplinary clinical-translational research program, funded by the National Institutes of Health, American Heart Association, and Helmsley Charitable Trust, applies advances in physiologic and genetic profiling, as well as diabetes technologies, to the study of hyperglycemia and cardiometabolic disease in pregnancy. She is passionate about making sure that pregnant and lactating individuals are included in the latest medical and scientific advances. Dr. Powe received an A.B. degree in Anthropology from Harvard College and an M.D. degree from Harvard Medical School. She trained in Internal Medicine at Brigham and Women's Hospital where she also served as Chief Medical Resident. She completed her fellowship in Endocrinology at Massachusetts General Hospital where she subsequently joined the faculty.

If you have questions for Dr. Powe, please email them to ONPA@mail.nih.gov.

Individuals requiring Sign Language Interpreters or other reasonable accommodations to facilitate their participation in this event should contact Susan Holbrook at susan.holbrook@nih.gov at least five (5) days prior to the commencement of the event.

Zoom Webinar

View the webinar: https://nih.zoomgov.com/j/1604598882?pwd=SYvd9A4L2EjC3O1ZyAP9JIDiEB6iBb.1